Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Post by lonc17on Dec 09, 2004 7:40pm

396 Views

Post# 8294098

spike up

First thing every morning I check my email and look for the news from ONC that will cause the shares to spike up. I have been waiting for years, or so it seems, but I remain convinced the day will come. The news will be Partnership or Glio Results or Mulitple NCI trials or perhaps something completely unexpected, but the day will come. A few weeks ago I sold some ONC (for the first time ever) and bought some Nortel at $3.52 CDN. Two days later I changed my mind and put it back into ONC. Since then, NT is up more than $1.00 and ONC is down about $2.00, but I don't mind at all because some day the news will be there... maybe even tomorrow!

Bullboard Posts

POET increases production capacity to meet AI demand